“We’re very excited that Oligonol(R) has achieved GRAS status,” said Steve Yamada, president of Maypro Industries. “Food products in Japan ranging from functional drinks to cookies have included Oligonol(R) based on its beneficial properties and we’re excited to now offer it to food companies in the United States.”
Oligonol(R) is a unique, proprietary form of lychee fruit extract with significantly improved bioavailability. For centuries, lychee fruit has been a well-known beauty remedy throughout Asia. Lychee was the favored fruit among the Tang Dynasty in China where it was utilized by the Emperor and his concubines for longevity and beauty. With a polyphenol concentration second only to strawberry, lychee fruit is a potent antioxidant that has proven beneficial for a number of health conditions. Clinical studies with Oligonol(R) have demonstrated benefits for skin health through improving blood flow to the subdermal layer protecting it from damage caused by UV light and free radicals. Other studies with Oligonol(R) have shown improved cardiovascular function, reduction of visceral fat as well as reduction of exercise fatigue.
Oligonol(R) has been successfully marketed in Japan as a functional ingredient for supplements, cosmetics and food. In 2007, Oligonol(R) was approved as a New Dietary Ingredient by the FDA where it was launched as a nutritional supplement soon after. For more information about Oligonol(R), contact Maypro Industries at (914) 251-0701 or visit its Web site at www.maypro.com.
Serving the nutritional industry for 30 years, Maypro Group is a privately held, global supplier of nutraceutical ingredients to the nutritional supplement, sports nutrition, pet & veterinary, cosmetic, functional food and fine chemical industries. Maypro also has received a minority investment form Marubeni America Corporation, the U.S. subsidiary of one of the five largest Japanese general trading companies with total revenues of more than US $75 billion and 125 offices worldwide. Maypro is headquartered in Purchase, N.Y., and has offices in Los Angeles, Tokyo and Shanghai. Maypro represents some of the world’s largest nutraceutical ingredient manufacturers and supplies high-quality ingredients in the U.S., Japan, Europe, Latin America and throughout Asia. Maypro has established itself as an industry innovator. It was the first to introduce such leading ingredients as Coenzyme Q10 (CoQ10), chondroitin, glucosamine, alpha-lipoic acid and AHCC(R) medicinal mushroom in the U.S. market and launched the leading U.S. and European patented, branded ingredients in Japan. For more information, visit the Maypro Web site at www.maypro.com.